CN101822693A - Medicine treating tympanitis - Google Patents
Medicine treating tympanitis Download PDFInfo
- Publication number
- CN101822693A CN101822693A CN201010159443A CN201010159443A CN101822693A CN 101822693 A CN101822693 A CN 101822693A CN 201010159443 A CN201010159443 A CN 201010159443A CN 201010159443 A CN201010159443 A CN 201010159443A CN 101822693 A CN101822693 A CN 101822693A
- Authority
- CN
- China
- Prior art keywords
- grams
- effect
- medicine
- tympanitis
- otitis media
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 208000025301 tympanitis Diseases 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title description 2
- 239000000843 powder Substances 0.000 claims abstract description 12
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 4
- 206010033078 Otitis media Diseases 0.000 claims description 11
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 241000972155 Moschus Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 208000002193 Pain Diseases 0.000 abstract description 11
- 230000036407 pain Effects 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 241000276401 Batrachoididae gen. sp. Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- KNXVOGGZOFOROK-UHFFFAOYSA-N trimagnesium;dioxido(oxo)silane;hydroxy-oxido-oxosilane Chemical compound [Mg+2].[Mg+2].[Mg+2].O[Si]([O-])=O.O[Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O KNXVOGGZOFOROK-UHFFFAOYSA-N 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 244000153234 Hibiscus abelmoschus Species 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 208000024035 chronic otitis media Diseases 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000243684 Lumbricus Species 0.000 description 3
- 241000237636 Pheretima Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000717739 Boswellia sacra Species 0.000 description 2
- 206010014020 Ear pain Diseases 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000158704 Monopterus albus Species 0.000 description 2
- 241001057584 Myrrha Species 0.000 description 2
- 206010033081 Otitis media chronic Diseases 0.000 description 2
- 201000010354 chronic purulent otitis media Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 210000000959 ear middle Anatomy 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 208000022760 infectious otitis media Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002690 local anesthesia Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- UQWIHDZMOYEOHL-YXAZDFSTSA-N (2s)-5-(diaminomethylideneamino)-2-[[8-[[(3s,5r,8r,9s,10s,11r,13r,14s,17r)-11,14-dihydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-8-oxooctanoyl]amino]pentanoic acid Chemical compound C=1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@@H](C[C@H]5CC4)OC(=O)CCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C)[C@H](O)C[C@@]32C)C=CC(=O)OC=1 UQWIHDZMOYEOHL-YXAZDFSTSA-N 0.000 description 1
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- VOZHMAYHYHEWBW-NVOOAVKYSA-N Bufotalin Chemical class C=1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C)CC[C@H](O)C[C@H]5CC[C@H]4[C@@]3(O)C[C@@H]2OC(=O)C)C=CC(=O)OC=1 VOZHMAYHYHEWBW-NVOOAVKYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000010315 Mastoiditis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 201000002014 Suppurative Otitis Media Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- ATLJNLYIJOCWJE-CWMZOUAVSA-N bufogenin Chemical class C=1([C@H]2C[C@H]3O[C@@]43[C@H]3[C@@H]([C@]5(CC[C@H](O)C[C@H]5CC3)C)CC[C@@]42C)C=CC(=O)OC=1 ATLJNLYIJOCWJE-CWMZOUAVSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 229960002588 cefradine Drugs 0.000 description 1
- RDLPVSKMFDYCOR-UEKVPHQBSA-N cephradine Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CCC=CC1 RDLPVSKMFDYCOR-UEKVPHQBSA-N 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000008629 longdanxiegan Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a medicine treating tympanitis, which comprises 100g fresh eel blood, 10g earthworm dried powder, 5g musk dried powder, 2g toadfish dried powder and 50g French chalk. When used to treat tympanitis, the invention has the effects of quick curative effect, stopping pain, clearing heat and toxic material, eliminating putridity and engendering the new, good curative effect, short treatment period, convenient use and security. The invention is applicable to the clinical treatment of tympanitis.
Description
Technical field
What the present invention proposed is the Chinese medicine of field of medicaments, specifically a kind of medicine for the treatment of otitis media.
Background technology
Otitis media is commonly called as " mashed ear ", is the inflammation of mucosa of tympanic cavity.Pathogenic bacteria enters tympanum, and when resistance weakens or bacteriotoxin just produces inflammation when strengthening, it shows as in ear pain (increase the weight of night), heating, aversion to cold, bitter taste, urine is red or yellow, constipation, auditory dysesthesia etc.As the perforation of ear drum, in ear can flow out pus, and pain can alleviate, and normal and chronic mastoiditis exists simultaneously.Acute stages treated is not thorough, can change chronic otitis media into, and with body constitution, climate change, the regular liquid of suppurating of in ear meeting, time is lacked for a long time, and delay for many years.The traditional Chinese medical science is called primary disease " otopyosis ", " chronic suppurative otitis media ", thinks to cause because of dampness-heat in the liver and gallbladder (fire) pathogen is in vogue.
The treatment chronic suppurative otitis media: drip ear with Monopteri albi blood, observe 63 examples, the lighter 1 time, heavy person can take effect for 2 times.Method: Monopterus albus (Zuiew) is placed in the clear water supported 6-8 hour.Time spent clamps the Monopterus albus (Zuiew) cervical region with tweezers or mosquito forceps, with the shears of sterilizing its tail is cut off, and allows blood drip in the ear, lies on one's side 20-40 minute.Before dripping medicine, need to suffer from ear with 3% hydrogen peroxide or normal saline earlier and clean, dry.
The Chinese patent medicine of data otitis media commonly used has:
1, cefradine capsule, each 1-2 grain, every day 4 times.
2, LONGDAN XIEGAN WAN, each 9 grams, every day 3 times.
3, Rhizoma Coptidis supernatant sheet, each 4, every day 3 times.
4, creat lactone sheet, each 4, every day 3 times.
Autotherapy proved recipe commonly used has:
1,1 dose of Caulis Lonicerae 30 gram, Radix Glycyrrhizae 10 grams, decoction every day, serve on 3-4 day.
2,1 dose of each 30 gram of Herba Taraxaci, Herba Plantaginis, Herba Violae, every day, divide 3 decoctions, serve on 3-4 day.
3, Flos Chrysanthemi Indici 12 grams, Radix Semiaquilegiae 10 grams, Radix Salviae Miltiorrhizae 15 grams, Rhizoma Alismatis 15 grams, Herba Hedyotidis Diffusae 30 grams divide 2 decoctions.
4, Bulbus Allii 1 lobe, 10 milliliters of distilled water are cleaned Bulbus Allii and are mashed extracting juice and distilled water mixing, an ear.
The Chinese patent medicine that is adopted still be the common drawback that all exists of autonomous medication be that curative effect is slow, can not play the effect that takes effect immediately.
Summary of the invention
In order to improve the treatment speed of chronic otitis media, and obtain notable therapeutic effect, the present invention proposes a kind of medicine for the treatment of otitis media.This medicine reaches the effect that diminishes inflammation, removes the rotten and lets fresh grow by the combination of animal formulation, solves the treatment speed of acute and chronic otitis media and the technical problem of effect.
The scheme that technical solution problem of the present invention is adopted is: be made up of bright Sanguis Monopteri albi 100 grams, earthworm dry powder 10 grams, Moschus dry powder 5 grams, Venenum Bufonis dry powder 2 grams and Pulvis Talci 50 grams.
Good effect, the medicine that the present invention treats otitis media have that curative effect is fast, pain relieving, heat-clearing and toxic substances removing and the effect of removing the rotten and letting fresh grow.Its curative effect height, treatment cycle weak point, easy to use, safe.Use in the clinical treatment of suitable various otitis media.
The specific embodiment
Form by bright Sanguis Monopteri albi 100 grams, earthworm dry powder 10 grams, Moschus dry powder 5 grams, Venenum Bufonis dry powder 2 grams and Pulvis Talci 50 grams.Mix furnishing paste, freezing preservation.
Use: made medicine unguentum is spread upon in the auditory meatus, every day 2 times, before medicine-feeding next time, with after last time the medicine of going up cleaned up, add medicine to again, next time until recovery from illness with 10% hydrogen peroxide.
The effect of Sanguis Monopteri albi: dispel the wind, invigorate blood circulation, tonifying YANG.Control facial hemiparalysis, otalgia, epistaxis, tinea, fistula.
The effect of Lumbricus: Chinese medicine claims Pheretima, Pheretima salty in the mouth cold in nature.Its salty in the mouth, cold in nature.Function is heat clearing away, spasmolytic, Zhichuan, diuresis.Cure mainly that hyperpyrexia is manic, convulsion with spasms, headache conjunctival congestion, the diseases such as expectorant heat, apoplexy, hemiplegia of panting.The conventional Chinese medicine of diseases such as damp invasion of lower energizer urinary tract infection such as Chinese traditional treatment prostate, this side is an ancient prescription among the people.Pheretima provides gets liquid the good effect that cloperastine is breathed heavily of deciding is arranged.The Lumbricus ash is controlled alopecia with the Oleum Rosae Rugosae mixing energy.
The effect of Moschus: Moschus is used for sore swollen toxin, laryngopharynx swelling and pain, and the hot fragrant row of this product looses, and good blood circulation promoting and dispersing pathogen accumulation is arranged, the reducing swelling and alleviating pain effect, for oral administration, external all has good effect.With controlling sore swollen toxin, normal and Realgar, Olibanum, the same usefulness of Myrrha, the ball that disappears of promptly waking up, or with Calculus Bovis, Olibanum, Myrrha with usefulness; With controlling laryngopharynx swelling and pain, can with compatibilities such as Calculus Bovis, Venenum Bufonis, Margarita, as LIUSHEN WAN.
The effect of Venenum Bufonis: the plain class of bufotalin class gamabufotoxin all has cardiotonic, resist myocardial ischemia again, anticoagulation, boost, shock, excited cerebral cortex and respiratory center, antiinflammatory, analgesia and local anesthesia effect.Bufogenin class and cinobufacin all have antitumor action, and can leukocyte increasing, anti-lonizing radiation; Also have antitussive, increase effects such as immunity, resisting fatigue, excited intestinal tube and uterine smooth muscle.
Talcous effect: be used to regulate the denseness of made unguentum, be convenient in auditory meatus, retain, the effect of blotting in addition simultaneously.
The synergism of ingredient: utilize dispeling the wind of Sanguis Monopteri albi, the effect of invigorating blood circulation, utilize Lumbricus heat clearing away effect, utilize the Moschus blood circulation promoting and dispersing pathogen accumulation, the reducing swelling and alleviating pain effect, utilize Venenum Bufonis antiinflammatory, analgesia and local anesthesia effect, make the otitis media affected part play quick convergence, heat clearing away, blood circulation promoting and dispersing pathogen accumulation, reducing swelling and alleviating pain, antiinflammatory, analgesia and anesthetic action.Make it to produce invigorate blood circulation, antiinflammatory, pain relieving, the effect of removing the rotten and letting fresh grow.
Advantage
Utilize Drug therapy otitis media of the present invention have that curative effect is fast, antiinflammatory is effective, and can relieve the pain immediately, wound surface recovers fast, cure rate is high characteristics.
The patient who utilizes medicine of the present invention that 50 examples are suffered from acute and chronic otitis media and suppurative otitis media carries out therapeutic test, proves that its effective percentage reaches 100%, and cure rate reaches 98%.The medicine that proof the present invention treats otitis media can produce therapeutical effect really, and healing speed is fast, therapeutic effect good, relapse rate is low, patient's no pain.
Claims (1)
1. a medicine for the treatment of otitis media is characterized in that: be made up of bright Sanguis Monopteri albi 100 grams, earthworm dry powder 10 grams, Moschus dry powder 5 grams, Venenum Bufonis dry powder 2 grams and Pulvis Talci 50 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010159443A CN101822693A (en) | 2010-04-29 | 2010-04-29 | Medicine treating tympanitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010159443A CN101822693A (en) | 2010-04-29 | 2010-04-29 | Medicine treating tympanitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101822693A true CN101822693A (en) | 2010-09-08 |
Family
ID=42686996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010159443A Pending CN101822693A (en) | 2010-04-29 | 2010-04-29 | Medicine treating tympanitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101822693A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247335A (en) * | 2011-06-02 | 2011-11-23 | 江苏省中医药研究院 | Bufalin dry powder inhalant as well as preparation method and application thereof |
| CN102247336A (en) * | 2011-06-02 | 2011-11-23 | 陈彦 | Bufothionine dry powder inhaler, and its preparation method and application |
| CN103656297A (en) * | 2013-12-16 | 2014-03-26 | 青岛百瑞吉生物工程有限公司 | Chinese drug agentia for treating tympanitis and preparation method of Chinese drug agentia |
-
2010
- 2010-04-29 CN CN201010159443A patent/CN101822693A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247335A (en) * | 2011-06-02 | 2011-11-23 | 江苏省中医药研究院 | Bufalin dry powder inhalant as well as preparation method and application thereof |
| CN102247336A (en) * | 2011-06-02 | 2011-11-23 | 陈彦 | Bufothionine dry powder inhaler, and its preparation method and application |
| CN102247336B (en) * | 2011-06-02 | 2013-03-13 | 陈彦 | Bufothionine dry powder inhaler, and its preparation method and application |
| CN103656297A (en) * | 2013-12-16 | 2014-03-26 | 青岛百瑞吉生物工程有限公司 | Chinese drug agentia for treating tympanitis and preparation method of Chinese drug agentia |
| CN103656297B (en) * | 2013-12-16 | 2016-01-27 | 卞佳林 | A kind of Chinese drugs agentia for the treatment of otitis media and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705883B (en) | One treats dermopathic medicine and preparation | |
| CN104352587B (en) | A kind of ointment for treating rhinitis | |
| CN102363039B (en) | Chinese medicine for treating rhinitis | |
| CN102772591A (en) | Hollow, ventilation and double-layer traditional Chinese medicine suppository for treating rhinitis and production method of traditional Chinese medicine suppository | |
| CN104000953A (en) | Traditional Chinese medicinal composition for treating rhinitis | |
| CN101822693A (en) | Medicine treating tympanitis | |
| CN101884727B (en) | Traditional Chinese medicine for treating rhinitis | |
| CN105012585A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN107875359A (en) | Traditional Chinese medicine pain-repairing physiotherapy medicinal film formula and preparation method thereof | |
| CN107334916A (en) | A kind of medicine for treating rhinitis | |
| CN110652544A (en) | Pharmaceutical composition for treating rhinitis and preparation method thereof | |
| CN104940729A (en) | Traditional Chinese medicine for treating cholelithiasis | |
| CN103110788B (en) | Traditional Chinese medicine patch for treating cough and dyspnea | |
| CN103127320B (en) | Itching relieving and anti-allergic Chinese medicinal compound umbilical patch | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN102133293B (en) | Medicament for treating rhinitis and preparation method thereof | |
| CN104857084A (en) | Traditional Chinese medicine medicated bath preparation for treating infantile exogenous fever | |
| CN105920380A (en) | Repair traditional Chinese medicine used for treating blood cell infected by flaviviridae | |
| CN105582154A (en) | Capsule medicine for treating wind cold induced migraine and preparation method | |
| CN104146558A (en) | Medical pillow capable of treating rhinitis | |
| CN103316202A (en) | Oral-dissolving sustained-release traditional Chinese medicine used for treating nasopharyngitis, and preparation method thereof | |
| CN102743589B (en) | Preparation method of Chinese medicine irrigation solution for treating garlic addiction type trichomonas vaginitis | |
| CN104107374A (en) | Traditional Chinese medicine capsule for treating cervical erosion and preparation method of traditional Chinese medicine capsule | |
| CN106110193A (en) | A kind of external skin ulcer convergence ointment and compound method thereof | |
| CN104997949A (en) | Traditional Chinese medicine for treating rhinitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100908 |